课题基金 / 基金详情

Induction of Apoptosis by HIV-1 vpr

Induction of Apoptosis by HIV-1 vpr
HIV-1 vpr 诱导细胞凋亡
批准号:
7073867
负责人:
VICENTE PLANELLES
金额:
$33.64万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2000
资助国家:
美国
项目状态:
已结题
起止时间:
2000-09-15 至 2005-12-31

项目摘要

项目成果

VICENTE PLANELLES的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
The VPR gene from HIV-1 encodes a 96 amino acid protein that induces apoptosis in infected lymphocytes. VPR induces apoptosis independently of the presence and function of p53, and in a manner that is mediated by activation of the cystine-aspartate proteases 3 and 8. The objective of the present study is to understand at a molecular level the mechanisms by which HIV-1 VPR induces apoptosis. Studies will first examine the possibility that VPR activates apoptosis pathways that normally function in response to death receptor activation or DNA damage. Studies will next be conducted to examine the degree of activation or inactivation of survival pathw0ays that normally prevent entry into apoptosis. Macrophages will then be examined to determine the impact of long-term, chronic infection by HIV-1 and the relationship to apoptosis. And lastly, studies will examine patterns of gene expression in an attempt to identify undefined cellular genes whose transcription is modified during VPR induced apoptosis. Specific aims of this proposal are: aim 1. To define the apoptosis signaling cascade that is activated by VPR. Aim 2. To examine the role of the survival pathway in VPR induced apoptosis. Aim 3. To examine the effect of VPR on the viability of primary macrophages. Aim 4. To identify differentially expressed cellular genes during VPR induced apoptosis.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Control of HIV-1 Transcription by CPSF6 and PP2A
  • 批准号:
    10693519
  • 项目类别:
  • 资助金额:
    $23.1万
  • 财政年份:
    2023
  • 负责人:
    VICENTE PLANELLES
  • 依托单位:
CRISPR/Cas9 technology toward understanding HIV latency in primary cells
  • 批准号:
    9203550
  • 项目类别:
  • 资助金额:
    $22.65万
  • 财政年份:
    2016
  • 负责人:
    VICENTE PLANELLES
  • 依托单位:
CRISPR/Cas9 technology toward understanding HIV latency in primary cells
  • 批准号:
    9303273
  • 项目类别:
  • 资助金额:
    $18.94万
  • 财政年份:
    2016
  • 负责人:
    VICENTE PLANELLES
  • 依托单位:
Preclinical Development of Ingenol and HDACi Toward HIV Eradication
  • 批准号:
    9049020
  • 项目类别:
  • 资助金额:
    $22.35万
  • 财政年份:
    2015
  • 负责人:
    VICENTE PLANELLES
  • 依托单位:
国内基金
海外基金
Epac1/2通过蛋白酶体调控中性粒细胞NETosis和Apoptosis在急性肺损伤中的作用研究
  • 批准号:
    LBY21H010001
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2020
  • 负责人:
    郑绪阳
  • 依托单位:
基于Apoptosis/Ferroptosis双重激活效应的天然产物AlbiziabiosideA的抗肿瘤作用机制研究及其结构改造
  • 批准号:
    81703335
  • 项目类别:
    青年科学基金项目
  • 资助金额:
    20.0万元
  • 批准年份:
    2017
  • 负责人:
    卫高菲
  • 依托单位:
双肝移植后Apoptosis和pyroptosis在移植物萎缩差异中的作用和供受者免疫微环境变化研究
  • 批准号:
    81670594
  • 项目类别:
    面上项目
  • 资助金额:
    58.0万元
  • 批准年份:
    2016
  • 负责人:
    陈昊
  • 依托单位:
Serp-2 调控apoptosis和pyroptosis 对肝脏缺血再灌注损伤的保护作用研究
  • 批准号:
    81470791
  • 项目类别:
    面上项目
  • 资助金额:
    73.0万元
  • 批准年份:
    2014
  • 负责人:
    董家鸿
  • 依托单位: